HIV reservoir study in people who control the virus
Part of Immune system & allergy, Infections clinical trials.
This study looks at the hidden virus and immune system in people living with HIV who can control the virus without medication or after certain treatments. It aims to understand why some people control HIV better, which could lead to new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV and have kept your viral load below 50 copies per ml for at least 12 months without taking HIV medication (elite controllers).
- Or you have kept your viral load below 2000 copies/ml with a CD4 count above 500 for at least 2 years without medication (viral controllers).
- Or you have kept your CD4 count above 500 and viral load below 10,000 copies/ml for at least 7 years without medication (long-term non-progressors).
- Or you stopped HIV medication after at least 12 months of treatment and had viral load below 500 copies/ml for at least 2 years off medication (post-treatment controllers).
- Or you received a bone marrow transplant for a non-HIV reason.
- You must not have active hepatitis B or C, certain heart conditions, cancer, or abnormal lab results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in the blood that help some people with HIV stay virus-free without medication for a long time. If you have controlled your HIV without drugs for at least 6 months, or are interested in pausing your medication to see if you can control the virus, this study may help guide future treatments.
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
This study looks at why some people with HIV on antiretroviral therapy still have small amounts of virus in their blood, while others achieve undetectable levels. Researchers will compare the two groups to understand the virus and immune system, which may help improve future treatments.
This study in Uganda looks at the HIV 'reservoir' (where the virus hides in the body) in people whose HIV is already well-controlled with medications. It involves blood draws and genetic testing to learn more about the virus.
This study looks at how platelets (small blood cells that help with clotting) might influence the hidden HIV that remains in your body even when your viral load is undetectable. The goal is to understand why some people's immune systems don't fully recover despite effective HIV treatment.
This study tests whether a combination approach, including a drug called nicotinamide (a form of vitamin B3) and other strategies, can reduce the hidden HIV reservoir enough to allow a temporary pause in antiretroviral therapy without the virus rebounding. It is for people who have well-controlled HIV and strong immune systems.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.